Alternus Clean Energy, Inc. Reports FY 2023 Financial Results
April 15, 2024 19:56 ET
|
Alternus Clean Energy
Alternus Clean Energy, Inc. Reports FY 2023 Audited Financial Results
- Revenue up by 17.5% YoY
- Gross profit up by 25% YoY
PIMCO Corporate & Income Strategy Fund, PIMCO High Income Fund, PIMCO Income Strategy Fund, PIMCO Income Strategy Fund II and PIMCO Corporate & Income Opportunity Fund Announce Final Results of Tender Offers for Auction Rate Preferred Shares
April 15, 2024 18:26 ET
|
PIMCO Account Management
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- PIMCO Corporate & Income Strategy Fund (NYSE: PCN), PIMCO High Income Fund (NYSE: PHK), PIMCO Income Strategy Fund (NYSE: PFL), PIMCO Income Strategy...
RYVYL Inc. Announces Launch of Proposed Underwritten Public Offering
April 15, 2024 16:27 ET
|
RYVYL Inc.
San Diego, CA, April 15, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger...
CNB Financial Corporation Reports First Quarter 2024 Results
April 15, 2024 16:05 ET
|
CNB Financial
CLEARFIELD, Pa., April 15, 2024 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“Corporation”) (NASDAQ: CCNE), the parent company of CNB Bank, today announced its earnings for the three months ended...
Redemption Date Announced for Warrants
April 15, 2024 09:20 ET
|
Cassava Sciences, Inc.
Monday, May 6, 2024 is Last and Final Day to Exercise Warrants.Once Redeemed, the Warrants Will Cease to Exist and Have No Value. AUSTIN, Texas, April 15, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences,...
HeartCore Signs 14th Go IPO Contract
April 15, 2024 08:30 ET
|
HeartCore Enterprises Inc.
NEW YORK and TOKYO, April 15, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based...
Inspired Reports Fourth Quarter and Full Year 2023 Results
April 15, 2024 08:00 ET
|
Inspired Entertainment, Inc.
Record Full Year 2023 Revenue of $323 million, up 15% versus prior year periodFull Year 2023 Net Income of $7.6 million, or 0.27 per shareRecord Full Year 2023 Adjusted EBITDA of $100.5 million4Q...
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 15, 2024 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
April 13, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, April 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Global Chemotherapy Market Size To Exceed USD 16.2 Billion By 2033 | CAGR of 6.54%
April 12, 2024 14:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 12, 2024 (GLOBE NEWSWIRE) -- The Global Chemotherapy Market Size is to Grow from USD 8.6 Billion in 2023 to USD 16.2 Billion by 2033, at a Compound Annual Growth Rate...